Hollywood Mark
Transaction: 07/06/2026
BUY
Change
+939
Price
$22.22
Filing
07/06/2026
Type
BUY
Zymeworks Inc.
ZYME • Biotechnology
$29.19
▼ -0.71 (-2.37%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.13B
Growth
29.2%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 28.8%Manageable debt level · 0.07Healthy liquidity · 5.52Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:01 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$29.19
Change-2.37%
Shares Out72.99M
Market Cap$2.13B
Enterprise Value$-252.56B
52W Range11.51 - 29.75
Beta1.13
P/E-0.05
P/S65.48
P/B0.03
P/FCF-12.81
EV/Sales-7,762.28
Price$29.19
Change-2.37%
Shares Out72.99M
Market Cap$2.13B
Enterprise Value$-252.56B
52W Range11.51 - 29.75
Beta1.13
P/E-0.05
P/S65.48
P/B0.03
P/FCF-12.81
EV/Sales-7,762.28
EV/EBITDA5.97
EV/FCF1,518.52
FCF Yield-7.81%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-87.33%
Profit Margin-76.56%
Debt/Eq0.07
Current Ratio5.52
Quick Ratio5.52
Revenue 5Y29.17%
Target$42.17
Target Upside44.47%
Target Median$43.00
Target Range32.00 - 55.00
Volume599.15K
Avg Volume645.93K
EPS Surprise-0.49
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
31/100
Why this score▼
Positive revenue growth · 28.8%Manageable debt level · 0.07Healthy liquidity · 5.52Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
95/100
Bullish
Bullish
20
Hold
2
Bearish
0
Price Target
2026-08-07
Low
$31.00
Mean
$41.75
Median
$42.50
High
$51.00
Insider Transactions
Recent executive and insider activity
Schneider Paul R
Transaction: 05/13/2026
OTHER
Change
0
Price
Not reported
Filing
05/15/2026
Type
OTHER
Schneider Paul R
Transaction: 05/13/2026
BUY
Change
+119,000
Price
Not reported
Filing
05/15/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hollywood Mark | BUY | +939 | $22.22 | 07/06/2026 | 07/06/2026 |
| Schneider Paul R | OTHER | 0 | Not reported | 05/13/2026 | 05/15/2026 |
| Schneider Paul R | BUY | +119,000 | Not reported | 05/13/2026 | 05/15/2026 |
| Schneider Paul R | BUY | +178,000 | $24.57 | 05/13/2026 | 05/15/2026 |
| Platshon Scott | OTHER | 0 | Not reported | 04/09/2026 | 04/10/2026 |
| Platshon Scott | OTHER | +167,000 | $22.99 | 04/09/2026 | 04/10/2026 |
| Schayowitz Adam | OTHER | +167,000 | $16.92 | 04/09/2026 | 04/10/2026 |
| Schayowitz Adam | OTHER | 0 | Not reported | 04/09/2026 | 04/10/2026 |
| Platshon Scott | OTHER | +111,111 | Not reported | 04/09/2026 | 04/10/2026 |
| Platshon Scott | BUY | +70,000 | $27.35 | 04/09/2026 | 04/10/2026 |
| Platshon Scott | BUY | +76,000 | Not reported | 04/09/2026 | 04/10/2026 |
| Schayowitz Adam | OTHER | +111,111 | Not reported | 04/09/2026 | 04/10/2026 |
| Schayowitz Adam | BUY | +70,000 | $27.35 | 04/09/2026 | 04/10/2026 |
| Schayowitz Adam | BUY | +76,000 | Not reported | 04/09/2026 | 04/10/2026 |
| Stafford Kristin | BUY | +50,000 | Not reported | 04/06/2026 | 04/07/2026 |
| Stafford Kristin | BUY | +178,000 | $25.84 | 04/06/2026 | 04/07/2026 |
| Stafford Kristin | OTHER | 0 | Not reported | 04/01/2026 | 04/07/2026 |
| Mekan Sabeen | OTHER | 0 | Not reported | 02/01/2026 | 02/02/2026 |
| Mekan Sabeen | OTHER | +19,000 | Not reported | 02/01/2026 | 02/02/2026 |
| Mekan Sabeen | OTHER | +29,000 | $23.16 | 02/01/2026 | 02/02/2026 |